Characterization of adjacent E-box and nuclear factor 1-like DNA binding sequence in the human CYP1A2 promoter

Journal of Biochemical and Molecular Toxicology

Volumn 19, Issue 2, 2005, Pages 78-86

  Narvaez, Marta J ^a   Anderson, Garret R ^a   Pickwell, George V ^a   Quattrochi, Linda C ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

CYP1A2; HEPG2; NF1; Rat hepatocytes; USF

Indexed keywords

ANTIBODY; CYTOCHROME P450 1A2; ISOPROTEIN; NUCLEAR FACTOR I; NUCLEAR PROTEIN; UPSTREAM STIMULATORY FACTOR 1; UPSTREAM STIMULATORY FACTOR 2;

ANIMAL CELL; ARTICLE; BINDING SITE; CELL CULTURE; COMPLEX FORMATION; CONTROLLED STUDY; DNA SEQUENCE; E BOX ELEMENT; ENZYME REGULATION; GENE ACTIVITY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MOLECULAR MECHANICS; MOLECULAR RECOGNITION; MUTATION; NONHUMAN; PROMOTER REGION; PROTEIN DNA BINDING; PROTEIN PROTEIN INTERACTION; RAT; REPORTER GENE;

CCAAT-ENHANCER-BINDING PROTEINS; CELL LINE, TUMOR; CYTOCHROME P-450 CYP1A2; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; MUTATION; NFI TRANSCRIPTION FACTORS; PROMOTER REGIONS (GENETICS); TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 17644389138     PISSN: 10956670     EISSN: None     Source Type: Journal    
DOI: 10.1002/jbt.20063     Document Type: Article

References (36)

1. Gonzalez FJ. Molecular genetics of the P-450 superfamily. Pharmacol Ther 1990;45:1-38.
2. Dey A, Jones J, Nebert DW. Tissue- and cell type-specific expression of cytochrome P450 1A1 and cytochrome P450 1A2 mRNA in the mouse localized in situ hybridization. Biochem Pharmacol 1999;58:525-537.
3. Zhang J, Zhang Q-Y, Guo J, Zhou Y, Ding X. Identification and functional characterization of a conserved, nuclear factor 1-like element in the proximal promoter region of CYP1A2 gene specifically expressed in the liver and olfactory mucosa. J Biol Chem 2000;275:8895-8902.
4. Wei C, Caccavale RJ, Kehoe JJ, Thomas PE, Iba MM. CYP1A2 is expressed along with CYP1A1 in the human lung. Cancer Lett 2001;171:113-120.
5. Farin FM, Omiecinski CJ. Regiospecific expression of cytochrome P-450s and microsomal epoxide hydrolase in human brain tissue. J Toxicol Environ Health 1993;40:317-335.
6. Mercurio MG, Shiff SJ, Galbraith RA, Sassa S. Expression of cytochrome P450 mRNAs in the colon and the rectum in normal human subjects. Biochem Biophys Res Commun 1995;210:350-355.
7. Schmidt JV, Su GH-T, Reddy JK, Simon MC, Bradfield CA. Characterization of a murine Ahr null allele: Involvement of the Ah receptor in hepatic growth and development. Proc Natl Acad Sci USA 1996;93:6731-6736.
8. Fernandez-Salguero P, Pineau T, Hilbert DM, McPhail T, Lee SST, Kimura S, Nebert DW, Rudikoff S, Ward JM, Gonzalez FJ. Immune system impairment and hepatic fibrosis in mice lacking the dioxin-binding Ah receptor. Science 1995;268:722-726.
9. Ling G, Hauer CR, Gronostajski RM, Pentecost B, Ding X. Transcriptional regulation of rat CYP2A3 by nuclear factor 1: Identification of a novel NFI-A isoform, and evidence for tissue-selective interaction of NFI with the CYP2A3 promoter in vivo. J Biol Chem 2004;279:27888-27895.
10. Chung I, Bresnick E. Identification of positive and negative regulatory elements of the human cytochrome P4501A2 (CYP1A2) gene. Arch Biochem Biophys 1997;338:220-226.
11. Quattrochi LC, Vu T, Tukey RH. The human CYP1A2 gene and induction by 3-methylcholanthrene: A region of DNA that supports Ah-receptor binding and promoter-specific induction. J Biol Chem 1994;269:6949-6954.
12. Quattrochi LC, Shih H, Pickwell GV. Induction of the human CYP1A2 enhancer by phorbol ester. Arch Biochem Biophys 1998;350:41-48.
13. Pickwell GV, Shih H, Quattrochi LC. Interaction of upstream stimulatory factor proteins with an E-box located within the human CYP1A2 5′-flanking gene contributes to basal transcriptional gene activation. Biochem Pharmacol 2003;65:1087-1096.
14. Aklillu E, Carrillo JA, Makonnen E, Hellman K, Pitarque M, Bertilsson L, Ingelman-Sundberg M. Genetic polymorphisms of CYP1A2 in Ethiopians affecting induction and expression: Characterization of novel haplotypes with single-nucleotide polymorphisms in intron 1. Mol Pharmacol 2003;64:659-669.
15. Corchero J, Pimprale S, Kimura S, Gonzalez FJ. Organization of the CYP1A cluster on human chromosome 15: Implications for gene regulation. Pharmacogenetics 2000;11:1-6.
16. Gronostajski RM. Roles of the NF1/CTF gene family in transcription and development. Gene 2000;249:31-45.
17. Massari ME, Murre C. Helix-loop-helix proteins: Regulators of transcription in eucaryotic organisms. Mol Cell Biol 2000;20:429-440.
18. Li D, Schuetz EG, Guzelian PS. Hepatocyte culture in study of P450 regulation. Methods Enzymol 1991;206:335-344.
19. Kocarek TA, Schuetz EG, Strom SC, Fisher RA, Guzelian PS. Comparative analysis of P450 3A induction in primary cultures of rat, rabbit and human hepatocytes. Drug Metab Dispos 1994;23:415-421.
20. Kleinman HK, McGarvey ML, Hassell JR, Star VL, Cannon FB, Laurie GW, Martin GR. Basement membrane complexes with biological activity. Biochemistry 1985;25:312-318.
21. Denison MS, Fisher JM, Whitlock JP Jr. Inducible, receptor-dependent protein-DNA interactions at a dioxin-responsive transcriptional enhancer. Proc Natl Acad Sci USA 1988;85:2528-2532.
22. Strand P, Carlsson L, Rask K, Skrtic S, Ekberg S, Hedin L, Oscarsson J, Jansson JO. Growth hormone induces CCAAT/enhancer binding protein alpha (C/EBPalpha) in cultured rat hepatocytes. J Hepatol 2000;32:618-626.
23. Shih HM, Liu Z, Towle HC. Two CACGTG motifs with proper spacing dictate the carbohydrate regulation of hepatic gene transcription. J Biol Chem 1995;270:21991-21997.
24. Black VH, Quattrochi LC. Molecular cloning of the guinea pig CYP1A2 gene 5′-flanking region: Identification of functional AHRE and characterization of CYP1A2 expression in GPC16 cells. Drug Metab Dispos 2004;32:595-602.
25. Odenthal M, Spindler MP, Kerres K, Dienes HP, Schirmacher P. A critical function of USF in HGF gene regulation mediated by a multiconsensus region. Biochem Biophy Res Commun 2002;296:374-382.
26. Shih H, Pickwell GV, Guenette DK, Bilir B, Quattrochi LC. Species differences in hepatocyte induction of CYP1A1 and CYP1A2 by omeprazole. Hum Exp Toxicol 1999;18:95-105.
27. Chung I, Bresnick E. Regulation of the constitutive expression of the human CYP1A2 gene: Cis elements and their interactions with proteins. Mol Pharmacol 1995;47:677-685.
28. Schrem H, Klempnauer J, Borlak J. Liver-enriched transcription factors in liver function and development. Part I: The hepatocyte nuclear factor network and liver-specific gene expression. Pharmacol Rev 2002;54:129-158.
29. Odom DT, Zizlsperger N, Gordon DB, Bell GW, Rinaldi NJ, Murray HL, Volkert TL, Schreiber J, Rolfe PA, Gifford DK, Fraenkel E, Bell GI, Young RA. Control of pancreas and liver gene expression by HNF transcription factors. Science 2004;303:1378-1381.
30. Lanigan TM, Russo AF. Binding of upstream stimulatory factor and a cell-specific activator to the calcitonin/calcitonin gene-related peptide enhancer. J Biol Chem 1997;272:18316-18324.
31. Garcia C, Nieto A. Two progesterone-dependent endometrial nuclear factors bind to an E-box in the rabbit uteroglobin gene promoter: Involvement in tissue-specific transcription. Arch Biochem Biophys 1999;362:301-308.
32. Heckert LL, Daggett MAF, Chen J. Multiple promoter elements contribute to activity of the follicle-stimulating hormone receptor (FSHR) gene in testicular Sertoli cells. Mol Endocrinol 1998;12:1499-1512.
33. Barker CW, Fagan JB, Pasco DS. Down-regulation of P4501A1 and P4501A2 mRNA expression in isolated hepatocytes by oxidative stress. J Biol Chem 1994;269:3985-3990.
34. Morel Y, Mermod N, Barouki R. An autoregulatory loop controlling CYP1A1 gene expression: Role of H2O2 and NF1. Mol Cell Biol 1999;19:6825-6832.
35. Pognonec P, Kato H, Roeder RG. The helix-loop-helix/leucine repeat transcription factor USF can be functionally regulated in a redox-dependent manner. J Biol Chem 1992;267:24563-24567.
36. Swanson HI, Yang J-H. Specificity of DNA binding of the c-Myc/Max and ARNT/ARNT dimers at the CACGTG recognition site. Nucleic Acids Res 1999;27:3205-3212.